Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
Franchimont N
the EC50 value shifts to 39
transvalensis ATCC 6865 is 0
leading to activation of AMPK
and improved IGF1R margins relative to the previously described compounds
Lenalidomide Catalog No.:M8013-2 Franchimont NLenalidomide, also known as CC 5013, is the thalidomide analog with potential antineoplastic activity. Lenalidomide inhibits TNF alpha production, stimulates T cells, reduces serum levels of the cytokines vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), and inhibits angiogenesis. This agent also promotes G1 cell cycle arrest and apoptosis of malignant cells. Lenalidomide is an approved drug. Product information CAS